Shabbir Chowdhury, MD
Psychiatry · Fayetteville, NCNPI 1760486617
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,028 and has fallen 97.0% since, to $31 in 2025.
Across 178 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$536
- Otsuka America Pharmaceutical, Inc.$452
- Lundbeck LLC$329
- AbbVie$296
- Takeda Pharmaceuticals U.S.A., Inc.$199
- Sunovion Pharmaceuticals Inc.$178
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,415100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 25 | $536 |
| Otsuka America Pharmaceutical, Inc. | 26 | $452 |
| Lundbeck LLC | 17 | $329 |
| AbbVie(2 entities) | 16 | $296 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $199 |
| Sunovion Pharmaceuticals Inc. | 16 | $178 |
| Supernus Pharmaceuticals, Inc. | 5 | $167 |
| Alkermes, Inc. | 4 | $165 |
| Corium, LLC | 7 | $138 |
| Jazz Pharmaceuticals Inc. | 7 | $117 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $95 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| Neurocrine Biosciences, Inc. | 5 | $85 |
| Idorsia Pharmaceuticals US Inc | 3 | $58 |
| Avanir Pharmaceuticals, Inc. | 4 | $58 |
| Arbor Pharmaceuticals, Inc. | 1 | $57 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Abbott | 1 | $51 |
| Eisai Inc. | 3 | $49 |
| Validus Pharmaceuticals LLC | 3 | $40 |
| Neos Therapeutics, LP | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Shire North American Group Inc | 2 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Harmony Biosciences LLC | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Tris Pharma Inc | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$400
- QELBREE$124
- SPRAVATO$122
- ARISTADA INITIO$100
How this compares
$3,415 in reported general payments places this provider in the 85th percentile of 1,108 psychiatry providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl ErMemantine Hcl | 15 | $1,745 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 32 | $710 |
| Bupropion XlBupropion Hcl | 52 | $701 |
| Alprazolam ErAlprazolam | 12 | $344 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $279 |
| Trazodone Hcl | 28 | $240 |
| Quetiapine Fumarate | 30 | $186 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $147 |
| Alprazolam | 49 | $142 |
| Clonazepam | 39 | $139 |
| Aripiprazole | 23 | $121 |
| Zolpidem Tartrate | 38 | $108 |
| Diazepam | 13 | $75 |
| Buspirone Hcl | 14 | $36 |
| Sertraline Hcl | 15 | $19 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Fayetteville
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
- James BarkerHickory$2.1M
- Brian FarahWinston Salem$605K
- Krishna TalluriMorrisville$591K
- Ramesh GihwalaGastonia$545K
- Keshavpal ReddyGreensboro$480K
- Robert MilletRaleigh$476K
- Steven SzaboDurham$360K
- David JoyeAlbemarle$280K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.